Lista de obras -

A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis

artículo científico publicado en 2014

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

artículo científico publicado en 2020

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

artículo científico publicado en 2003

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

artículo científico publicado en 2020

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

artículo científico publicado en 2008

Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy

artículo científico publicado en 2014

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

artículo científico publicado en 2017

Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease

artículo científico publicado en 2007

Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series

artículo científico publicado en 2010

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

artículo científico publicado en 2012

IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab

artículo científico publicado en 2009

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease